Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Autologous immune strategies to reduce the risk of leukemic relapse: consideration for IL-15.

Autologous immune strategies to reduce the risk of leukemic relapse: consideration for IL-15. Best Pract Res Clin Haematol. 2006; 19(2):281-92.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.